Showing results (131-140 of 192) with videos related to

Sort By:
Pageof 20
Lung Cancer (Amsterdam, Netherlands)|July 31, 2007
DNA methylation profile of 28 potential marker loci in malignant mesotheliomaJeffrey A Tsou, Janice S Galler, Anil Wali, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2009
Comparison of iodine-123 metaiodobenzylguanidine (MIBG) scan and [18F]fluorodeoxyglucose positron emission tomography to evaluate response after iodine-131 MIBG therapy for relapsed neuroblastomaDenah R Taggart, Myo M Han, Alekist Quach, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 26, 2004
Combined effects of p53, p21, and pRb expression in the progression of bladder transitional cell carcinomaSunanda J Chatterjee, Ram Datar, David Youssefzadeh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2005
Molecular determinants of cetuximab efficacyDaniel Vallböhmer, Wu Zhang, Michael Gordon, et al.
Cancer Chemotherapy and Pharmacology|January 12, 2010
A phase I/II trial of vorinostat in combination with 5-fluorouracil in patients with metastatic colorectal cancer who previously failed 5-FU-based chemotherapyPeter M Wilson, Anthony El-Khoueiry, Syma Iqbal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2006
Phase I dose escalation of iodine-131-metaiodobenzylguanidine with myeloablative chemotherapy and autologous stem-cell transplantation in refractory neuroblastoma: a new approaches to Neuroblastoma Therapy Consortium StudyKatherine K Matthay, Jessica C Tan, Judith G Villablanca, et al.
Pageof 20